Phase II trial of Cystemustine, a new nitrosourea, as second-line treatment of malignant gliomas

1994

Supratentorial malignant gliomas represent 50 % of the primary malignant brain tumors [1, 2].

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

4

References

2

Citations